Nataliya Mushenkova
Lead Expert
Lead Expert
PHS VENTURES
Russian Federation
Biography
Natalya has extensive experience in molecular biology, genetic engineering and cellular biology, deep knowledge of oncology, carcinogenesis, immunology, pharmaceutical drug development. Before joining Pharmstandard Ventures (formerly Inbio Ventures), Natalya Mushenkova served as a scientific expert at IBC Generium since 2010. She received her Ph.D. in Immunology and Molecular Bilology from Institute of Bioorganic Chemistry. Her Ph.D. work was devoted to the development of muc-1 specific vaccine and study of its anti-tumor effects in mice. She graduated from Moscow State University, she was a student of educational program "Oncoimmunology the 3rd Millenium" sponsored by CRI.
Research Interest
Natalya has extensive experience in molecular biology, genetic engineering and cellular biology, deep knowledge of oncology, carcinogenesis, immunology, pharmaceutical drug development. Before joining Pharmstandard Ventures (formerly Inbio Ventures), Natalya Mushenkova served as a scientific expert at IBC Generium since 2010. She received her Ph.D. in Immunology and Molecular Bilology from Institute of Bioorganic Chemistry. Her Ph.D. work was devoted to the development of muc-1 specific vaccine and study of its anti-tumor effects in mice. She graduated from Moscow State University, she was a student of educational program "Oncoimmunology the 3rd Millenium" sponsored by CRI.
